{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T11:40:45Z","timestamp":1776858045360,"version":"3.51.2"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,10]]},"DOI":"10.7759\/cureus.92023","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:04:01Z","timestamp":1757570641000},"source":"Crossref","is-referenced-by-count":1,"title":["High Source Strength of Most Blister Packs Delivered for 125I Seed Brachytherapy: A Case Report"],"prefix":"10.7759","author":[{"given":"Masato","family":"Takanashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Sugahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masumi","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Hoshina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1562729","article-title":"Prostate and urinary microbiomes in prostate cancer development: focus on Cutibacterium acnes","volume":"15","author":"Fu F","year":"2025","unstructured":"Fu F, Yu Y, Wang B, et al.. Prostate and urinary microbiomes in prostate cancer development: focus on Cutibacterium acnes. Front Cell Infect Microbiol. 2025, 15:1562729. 10.3389\/fcimb.2025.1562729","journal-title":"Front Cell Infect Microbiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.70020","article-title":"The contemporary management of prostate cancer","author":"Chakrabarti D","year":"2025","unstructured":"Chakrabarti D, Albertsen P, Adkins A, et al.. The contemporary management of prostate cancer. CA Cancer J Clin. 2025, 10.3322\/caac.70020","journal-title":"CA Cancer J Clin"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s11604-020-00993-7","article-title":"Current status of prostate brachytherapy in Japan","volume":"38","author":"Yorozu A","year":"2020","unstructured":"Yorozu A. Current status of prostate brachytherapy in Japan. Jpn J Radiol. 2020, 38:934-41. 10.1007\/s11604-020-00993-7","journal-title":"Jpn J Radiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-018-1309-0","article-title":"Nationwide Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation (J-POPS): first analysis on survival","volume":"23","author":"Ito K","year":"2018","unstructured":"Ito K, Saito S, Yorozu A, et al.. Nationwide Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation (J-POPS): first analysis on survival. Int J Clin Oncol. 2018, 23:1148-59. 10.1007\/s10147-018-1309-0","journal-title":"Int J Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.brachy.2019.06.006","article-title":"Patient-reported health-related quality of life up to three years after the treatment with permanent brachytherapy: outcome of the large-scale, prospective longitudinal study in Japanese-Prostate Cancer Outcome Study by Permanent I-125 Seed Implantation (J-POPS)","volume":"18","author":"Koga H","year":"2019","unstructured":"Koga H, Naito S, Ishiyama H, et al.. Patient-reported health-related quality of life up to three years after the treatment with permanent brachytherapy: outcome of the large-scale, prospective longitudinal study in Japanese-Prostate Cancer Outcome Study by Permanent I-125 Seed Implantation (J-POPS). Brachytherapy. 2019, 18:806-13. 10.1016\/j.brachy.2019.06.006","journal-title":"Brachytherapy"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1118\/1.597316","article-title":"Comprehensive QA for radiation oncology: report of AAPM Radiation Therapy Committee Task Group 40","volume":"21","author":"Kutcher GJ","year":"1994","unstructured":"Kutcher GJ, Coia L, Gillin M, et al.. Comprehensive QA for radiation oncology: report of AAPM Radiation Therapy Committee Task Group 40. Med Phys. 1994, 21:581-618. 10.1118\/1.597316","journal-title":"Med Phys"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1118\/1.597966","article-title":"Code of practice for brachytherapy physics: report of the AAPM Radiation Therapy Committee Task Group No. 56. American Association of Physicists in Medicine","volume":"24","author":"Nath R","year":"1997","unstructured":"Nath R, Anderson LL, Meli JA, Olch AJ, Stitt JA, Williamson JF. Code of practice for brachytherapy physics: report of the AAPM Radiation Therapy Committee Task Group No. 56. American Association of Physicists in Medicine. Med Phys. 1997, 24:1557-98. 10.1118\/1.597966","journal-title":"Med Phys"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1118\/1.598721","article-title":"Permanent prostate seed implant brachytherapy: report of the American Association of Physicists in Medicine Task Group No. 64","volume":"26","author":"Yu Y","year":"1999","unstructured":"Yu Y, Anderson LL, Li Z, et al.. Permanent prostate seed implant brachytherapy: report of the American Association of Physicists in Medicine Task Group No. 64. Med Phys. 1999, 26:2054-76. 10.1118\/1.598721","journal-title":"Med Phys"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1118\/1.2959723","article-title":"Third-party brachytherapy source calibrations and physicist responsibilities: report of the AAPM Low Energy Brachytherapy Source Calibration Working Group","volume":"35","author":"Butler WM","year":"2008","unstructured":"Butler WM, Bice WS Jr, DeWerd LA, et al.. Third-party brachytherapy source calibrations and physicist responsibilities: report of the AAPM Low Energy Brachytherapy Source Calibration Working Group. Med Phys. 2008, 35:3860-5. 10.1118\/1.2959723","journal-title":"Med Phys"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1118\/1.4951734","article-title":"Guidelines by the AAPM and GEC-ESTRO on the use of innovative brachytherapy devices and applications: report of Task Group 167","volume":"43","author":"Nath R","year":"2016","unstructured":"Nath R, Rivard MJ, DeWerd LA, et al.. Guidelines by the AAPM and GEC-ESTRO on the use of innovative brachytherapy devices and applications: report of Task Group 167. Med Phys. 2016, 43:3178-205. 10.1118\/1.4951734","journal-title":"Med Phys"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2019.02.008","article-title":"GEC-ESTRO ACROP recommendations on calibration and traceability of LE-LDR photon-emitting brachytherapy sources at the hospital level","volume":"135","author":"Perez-Calatayud J","year":"2019","unstructured":"Perez-Calatayud J, Ballester F, Carlsson Tedgren \u00c5, et al.. GEC-ESTRO ACROP recommendations on calibration and traceability of LE-LDR photon-emitting brachytherapy sources at the hospital level. Radiother Oncol. 2019, 135:120-9. 10.1016\/j.radonc.2019.02.008","journal-title":"Radiother Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/jrr\/rrad063","article-title":"Current status and issues with the dosimetric assay of iodine-125 seed sources at medical facilities in Japan: a questionnaire-based survey","volume":"64","author":"Kojima T","year":"2023","unstructured":"Kojima T, Kawamura S, Otani Y, et al.. Current status and issues with the dosimetric assay of iodine-125 seed sources at medical facilities in Japan: a questionnaire-based survey. J Radiat Res. 2023, 64:962-6. 10.1093\/jrr\/rrad063","journal-title":"J Radiat Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.11323\/jjmp.43.1_1","article-title":"Technical report: quality assurance for 125I seed sources in permanent prostate brachytherapy. (Article in Japanese)","volume":"43","author":"Kojima T","year":"2023","unstructured":"Kojima T, Kawamura S, Otani Y, et al.. Technical report: quality assurance for 125I seed sources in permanent prostate brachytherapy. (Article in Japanese). Igaku Butsuri. 2023, 43:1-16. 10.11323\/jjmp.43.1_1","journal-title":"Igaku Butsuri"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s11604-006-0088-0","article-title":"Dosimetric consideration of individual 125I source strength measurement and a large-scale comparison of that measured with a nominal value in permanent prostate implant brachytherapy","volume":"24","author":"Takahashi Y","year":"2006","unstructured":"Takahashi Y, Ito A, Sumida I, et al.. Dosimetric consideration of individual 125I source strength measurement and a large-scale comparison of that measured with a nominal value in permanent prostate implant brachytherapy. Radiat Med. 2006, 24:675-9. 10.1007\/s11604-006-0088-0","journal-title":"Radiat Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-009-0914-3","article-title":"Verification of air-kerma strength of 125I seed for permanent prostate implants in Japan","volume":"14","author":"Sumida I","year":"2009","unstructured":"Sumida I, Koizumi M, Takahashi Y, et al.. Verification of air-kerma strength of 125I seed for permanent prostate implants in Japan. Int J Clin Oncol. 2009, 14:525-8. 10.1007\/s10147-009-0914-3","journal-title":"Int J Clin Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1120\/jacmp.v14i2.4082","article-title":"Source strength assay of iodine-125 seeds sealed within sterile packaging","volume":"14","author":"Otani Y","year":"2013","unstructured":"Otani Y, Yamada T, Kato S, et al.. Source strength assay of iodine-125 seeds sealed within sterile packaging. J Appl Clin Med Phys. 2013, 14:4082. 10.1120\/jacmp.v14i2.4082","journal-title":"J Appl Clin Med Phys"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/acm2.12000","article-title":"A method for confirming a third-party assay of I-125 seeds used for prostate implants","volume":"18","author":"Muryn JS","year":"2017","unstructured":"Muryn JS, Wilkinson DA. A method for confirming a third-party assay of I-125 seeds used for prostate implants. J Appl Clin Med Phys. 2017, 18:53-8. 10.1002\/acm2.12000","journal-title":"J Appl Clin Med Phys"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2006.05.052","article-title":"Quality assurance of I-125 seeds for prostate brachytherapy using an imaging plate","volume":"66","author":"Furutani S","year":"2006","unstructured":"Furutani S, Saze T, Ikushima H, et al.. Quality assurance of I-125 seeds for prostate brachytherapy using an imaging plate. Int J Radiat Oncol Biol Phys. 2006, 66:603-9. 10.1016\/j.ijrobp.2006.05.052","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/411753-high-source-strength-of-most-blister-packs-delivered-for-125i-seed-brachytherapy-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:04:03Z","timestamp":1757570643000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/411753-high-source-strength-of-most-blister-packs-delivered-for-125i-seed-brachytherapy-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,10]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.92023","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,10]]}}}